Initial Experience of Transforaminal Lumbar Endoscopic Discectomy in a Single Orthopedics Unit

单一骨科单位经椎间孔腰椎内镜椎间盘切除术的初步经验

阅读:1

Abstract

Objectives The objective of this study is to report the initial surgical experience, challenges faced, and the preliminary outcomes of our cases. Materials and methods A retrospective analysis of the first 10 patients operated with TELD in our unit was performed. Ethical approval was obtained from the Hospital Review Committee of Hamad Medical Corporation. Preparation time and surgical time were used to determine the learning curve of the surgeons. The Oswestry Disability Index (ODI) scores, which are routinely recorded preoperatively and then at two weeks and three months postoperatively, were used to assess the outcomes in this study. All the data was extracted from patients' records. The procedures were performed by two orthopedic spine surgeons. A total of 12 cases were booked for the TELD from April 2023 to February 2024. Two cases were converted to microscopic discectomy intraoperatively due to difficult access, and they were excluded from the study. Results Ten cases underwent TELD at the (L3/L4 - 1 case, L4/L5 - 8 cases and L5/ S1- 1 case) levels. All patients were male, and the mean age was 37.9 years (range: 24 to 48 years). Preparation time remained almost stable, while a downward trend was noticed in surgical time after the fourth case. The first and eighth operated cases did not show significant improvement in the ODI scores. The remaining patients had significant improvement in ODI scores, especially at three months postoperatively. Conclusion By virtue of our preliminary experience of the TELD, we realized that it is a useful procedure in properly selected patients with all the benefits of minimally invasive surgery. However, we found a relatively late resolution of preoperative symptoms as indicated by the ODI scores.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。